findmyKOL
Clinical trialNCT01969058CompletedPhase 2Interventional

Effect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4+ T Cell Recovery

SponsorAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other InfectionsEnrollment76HIV-1 Infection
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Puerto Rico
  • 5401 Puerto Rico Aids Clinical Trials Unit Crs

    San Juan, Puerto Rico

United States
  • 31788 Alabama Crs

    Birmingham, Alabama, United States

  • 601 University of California, Los Angeles Care Center Crs

    Los Angeles, California, United States

  • 801 University of California, San Francisco Hiv/aids Crs

    San Francisco, California, United States

  • 101 Massachusetts General Hospital (mgh) Crs

    Boston, Massachusetts, United States

  • 107 Brigham and Women'S Hosp. Actg Crs

    Boston, Massachusetts, United States

  • 2101 Washington University Therapeutics (wt) Crs

    St Louis, Missouri, United States

  • 31786 New Jersey Medical School Clinical Research Center Crs

    Newark, New Jersey, United States

  • 31787 University of Rochester Adult Hiv Therapeutic Strategies Network Crs

    Rochester, New York, United States

  • 3201 Chapel Hill Crs

    Chapel Hill, North Carolina, United States

  • 3203 Greensboro Crs

    Greensboro, North Carolina, United States

  • 2401 Cincinnati Crs

    Cincinnati, Ohio, United States

  • 2951 the Miriam Hospital (tmh) Actg Crs

    Providence, Rhode Island, United States

  • 3652 Vanderbilt Therapeutics (vt) Crs

    Nashville, Tennessee, United States

  • 31473 Houston Aids Research Team (hart) Crs

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Jul 2014
Primary completion
31 Aug 2016
Completion
30 Nov 2016
Last update posted
15 Oct 2024
Registered enrollment
76
Registry id
NCT01969058

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.